Autologous tumor-infiltrating lymphocyte cells
HV-IIT
Phase 1 mab terminated
Quick answer
Autologous tumor-infiltrating lymphocyte cells for Advanced Solid Tumor is a Phase 1 program (mab) at China SXT Pharmaceuticals with 1 ClinicalTrials.gov record(s).
Program details
- Company
- China SXT Pharmaceuticals
- Indication
- Advanced Solid Tumor
- Phase
- Phase 1
- Modality
- mab
- Status
- terminated